Demethyl-Cantharidin

Demethyl-Cantharidin

SCHEMBL19318920

O=C1OC(=O)[C@H]2C3CCC(O3)C12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 1.00
LMNA P02545 4/20 1.00
PPM1B O75688 4/20 1.00
SMN1; SMN2 Q16637 4/20 1.00
KDM4E B2RXH2 3/20 1.00
GMNN O75496 3/20 1.00
TFPI2 P48307 3/20 1.00
PMP22 Q01453 3/20 1.00
NFKB1 P19838 3/20 1.00
THPO P40225 3/20 1.00
RAB9A P51151 3/20 1.00
PPP1CC P36873 2/20 1.00
PPP5C P53041 2/20 1.00
PPP1CA P62136 2/20 1.00
TDP1 Q9NUW8 1/20 1.00
CYP2D6 P10635 1/20 1.00
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 2/20 0.35
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demethyl-Cantharidin SCHEMBL177729 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
Norcantharidin SCHEMBL29380910 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL9675442 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL3187662 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL3195020 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL6432892 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL9906842 1.00 TP53 (1.00) TP53LMNAPPM1BSMN1; SMN2KDM4E
SCHEMBL16938608 0.84 KDM4E (0.71) TP53LMNAPPM1BSMN1; SMN2KDM4E
SCHEMBL17695028 0.84 KDM4E (0.71) TP53LMNAPPM1BSMN1; SMN2KDM4E
SCHEMBL12599313 0.74 KDM4E (0.57) TP53LMNAPPM1BSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170253614-A1 HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253614-A1 HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS HAVCR2, HCCS, LIPC TP53 606/4885LMNA 2690/4885PPM1B 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.